Characterization of barley (Hordeum vulgare L.) NAC transcription factors suggests conserved functions compared to both monocots and dicots

<p>Abstract</p> <p>Background</p> <p>The NAC transcription factor family is involved in the regulation of traits in both monocots and dicots of high agronomic importance. Understanding the precise functions of the NAC genes can be of utmost importance for the improvement of cereal crop plants through plant breeding. For the cereal crop plant barley (<it>Hordeum vulgare </it>L.) only a few <it>NAC </it>genes have so far been investigated.</p> <p>Results</p> <p>Through searches in publicly available barley sequence databases we have obtained a list of 48 barley <it>NAC </it>genes (<it>HvNACs</it>) with 43 of them representing full-length coding sequences. Phylogenetic comparisons to Brachypodium, rice, and Arabidopsis NAC proteins indicate that the barley NAC family includes members from all of the eight NAC subfamilies, although by comparison to these species a number of <it>HvNACs </it>still remains to be identified. Using qRT-PCR we investigated the expression profiles of 46 <it>HvNACs </it>across eight barley tissues (young flag leaf, senescing flag leaf, young ear, old ear, milk grain, late dough grain, roots, and developing stem) and two hormone treatments (abscisic acid and methyl jasmonate).</p> <p>Conclusions</p> <p>Comparisons of expression profiles of selected barley <it>NAC </it>genes with the published functions of closely related <it>NAC </it>genes from other plant species, including both monocots and dicots, suggest conserved functions in the areas of secondary cell wall biosynthesis, leaf senescence, root development, seed development, and hormone regulated stress responses.</p

Traitement des troubles mentaux en milieu pénitentiaire [Treatment of mental disorders in prisons]

The practice of psychiatry and psychology in prisons is essential because of the high prevalence of mental disorders that is observed. Psychiatrists and psychologists, such as other health care professionals, should be affiliated to the health department and intervene in the therapeutic role, which must be distinguished from the role of the psychiatric expert mandated by the court. Therapy in prison is challenging because of the sometimes contradictory issues, at the interface of clinical, societal, security, legal and political fields. Health care professionals can thus be subject to important pressures or to ethical and deontological issues

Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine

Plasma levels of clozapine and olanzapine are lower in smokers than in nonsmokers, which is mainly due to induction of cytochrome P4501A2 (CYP1A2) by some smoke constituents. Smoking cessation in patients treated with antipsychotic drugs that are CYP1A2 substrates may result in increased plasma levels of the drug and, consequently, in adverse drug effects. Two cases of patients who smoked tobacco and cannabis are reported. The first patient, who was receiving clozapine treatment, developed confusion after tobacco and cannabis smoking cessation, which was related to increased clozapine plasma levels. The second patient, who was receiving olanzapine treatment, showed important extrapyramidal motor symptoms after reducing his tobacco consumption. The clinical implication of these observations is that smoking patients treated with CYP1A2 substrate antipsychotics should regularly be monitored with regard to their smoking consumption in order to adjust doses in cases of a reduction or increase in smoking

Recommandations de pratique clinique dans la schizophrénie : de la théorie à la mise en application

Résumé: Dans le cadre d'une étude rétrospective au sein d'une unité de réhabilitation ,nous avons cherché à examiner le degré de respect de recommandations de pratique clinique (RPC) abordant le traitement pharmacologique au long cours de la schizophrénie, par des médecins qui n'en ont qu'une connaissance indirecte. « The Expert Consensus Guideline for the treatment of schizophrenia » (« ECGTS ») a été retenu comme référence sur la base d'une comparaison avec cinq autres RPC principales. Sur un collectif de 20 patients, les recommandations de «l'ECGTS» sont totalement respectées dans 65 % des cas, partiellement respectées dans 10% et non respectées dans 25 %, démontrant ainsi que la pratique clinique est clairement perfectible (principalement dans le traitement des symptômes psychotiques et dépressifs). Cependant, le respect des RPC ne garantit pas forcément la résolution de tous les problèmes cliniques rencontrés : 12 patients sur 20 présentent des effets secondaires à l'évaluation clinique, et pour 8 d'entre eux, les recommandations à ce niveau sont respectées. Notre étude montre cependant que le choix et l'application d'une RPC n'est pas simple. Les RPC actuelles donnent peu ou pas d'instrument de mesure, ni de critère précis pour évaluer les problèmes cliniques auxquels elles font référence. L'avenir appartient donc à des RPC qui proposent, outre les recommandations cliniques elles-mêmes, les moyens de leur vérification et de leur application sur le terrain

Quantitative feasibility study of magnetocaloric energy conversion utilizing industrial waste heat

The main objective of this theoretical study was to investigate under which conditions a magnetic energy conversion device (MECD) - utilizing industrial waste heat - is economically feasible. Furthermore, it was evaluated if magnetic energy conversion (MCE) has the potential of being a serious concurrent to already existing conventional energy conversion technologies. Up-today the availability of magnetocaloric materials with a high Curie temperature and a high magnetocaloric effect is rather limited. Therefore, this study was mainly focused on applications with heat sources of low to medium temperature levels. Magnetic energy conversion machines, containing permanent magnets, are numerically investigated for operation conditions with different temperature levels, defined by industrial waste heat sources and environmental heat sinks, different magnetic field intensities and different frequencies of operation (number of thermodynamic cycles per unit of time). Theoretical modeling and numerical simulations were performed in order to determine thermodynamic efficiencies and the exergy efficiencies as function of different operation conditions. From extracted data of our numerical results, approximate values of the total mass and total volume of magnetic energy conversion machines could be determined. These important results are presented dependent on the produced electric power. An economic feasibility study supplements the scientific study. It shows an excellent potential of profitability for certain machines. The most important result of this article is that the magnetic energy conversion technology can be economically and technically competitive to or even beat conventional energy conversion technologies. This is true especially in those cases when large, low-exergy heat sources are at one's disposal. (C) 2012 Elsevier Ltd. All rights reserved

Traitement pharmacologique de la schizophrénie: évaluation comparative de la qualité des recommandations de pratique clinique [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia]

INTRODUCTION: Many clinical practice guidelines (CPG) have been published in reply to the development of the concept of "evidence-based medicine" (EBM) and as a solution to the difficulty of synthesizing and selecting relevant medical literature. Taking into account the expansion of new CPG, the question of choice arises: which CPG to consider in a given clinical situation? It is of primary importance to evaluate the quality of the CPG, but until recently, there has been no standardized tool of evaluation or comparison of the quality of the CPG. An instrument of evaluation of the quality of the CPG, called "AGREE" for appraisal of guidelines for research and evaluation was validated in 2002. AIM OF THE STUDY: The six principal CPG concerning the treatment of schizophrenia are compared with the help of the "AGREE" instrument: (1) "the Agence nationale pour le développement de l'évaluation médicale (ANDEM) recommendations"; (2) "The American Psychiatric Association (APA) practice guideline for the treatment of patients with schizophrenia"; (3) "The quick reference guide of APA practice guideline for the treatment of patients with schizophrenia"; (4) "The schizophrenia patient outcomes research team (PORT) treatment recommendations"; (5) "The Texas medication algorithm project (T-MAP)" and (6) "The expert consensus guideline for the treatment of schizophrenia". RESULTS: The results of our study were then compared with those of a similar investigation published in 2005, structured on 24 CPG tackling the treatment of schizophrenia. The "AGREE" tool was also used by two investigators in their study. In general, the scores of the two studies differed little and the two global evaluations of the CPG converged; however, each of the six CPG is perfectible. DISCUSSION: The rigour of elaboration of the six CPG was in general average. The consideration of the opinion of potential users was incomplete, and an effort made in the presentation of the recommendations would facilitate their clinical use. Moreover, there was little consideration by the authors regarding the applicability of the recommendations. CONCLUSION: Globally, two CPG are considered as strongly recommended: "the quick reference guide of the APA practice guideline for the treatment of patients with schizophrenia" and "the T-MAP"